Medical Developments International Limited (MVP.AX)
AUD 0.4
(-2.47%)
AUD 0.4
(-2.47%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -7.44 Million AUD | 66.3% |
| 2023 | -22.1 Million AUD | -25.68% |
| 2022 | -17.58 Million AUD | 47.08% |
| 2021 | -33.22 Million AUD | -172.63% |
| 2020 | -12.18 Million AUD | 52.09% |
| 2019 | -25.43 Million AUD | -400.76% |
| 2018 | 8.45 Million AUD | 770.21% |
| 2017 | -1.26 Million AUD | 75.44% |
| 2016 | -5.13 Million AUD | -3373.25% |
| 2015 | 157 Thousand AUD | -92.16% |
| 2014 | 2 Million AUD | 196.3% |
| 2013 | 676 Thousand AUD | 119.41% |
| 2012 | -3.48 Million AUD | 1.64% |
| 2011 | -3.54 Million AUD | -98.71% |
| 2010 | -1.78 Million AUD | -593.39% |
| 2009 | -257 Thousand AUD | 45.67% |
| 2008 | -473 Thousand AUD | -456.47% |
| 2007 | -85 Thousand AUD | -108.3% |
| 2006 | 1.02 Million AUD | -29.77% |
| 2005 | 1.45 Million AUD | 82.48% |
| 2004 | 799 Thousand AUD | -73.54% |
| 2003 | 3.02 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -7.44 Million AUD | 66.3% |
| 2024 Q4 | -7.44 Million AUD | 0.0% |
| 2024 Q2 | -13.27 Million AUD | 0.0% |
| 2023 FY | -22.1 Million AUD | -25.68% |
| 2023 Q2 | -34.43 Million AUD | 0.0% |
| 2023 Q4 | -22.1 Million AUD | 0.0% |
| 2022 FY | -17.58 Million AUD | 47.08% |
| 2022 Q2 | -25.34 Million AUD | 0.0% |
| 2022 Q4 | -17.58 Million AUD | 0.0% |
| 2021 Q2 | -30.21 Million AUD | 0.0% |
| 2021 Q4 | -33.22 Million AUD | 0.0% |
| 2021 FY | -33.22 Million AUD | -172.63% |
| 2020 Q2 | -19.6 Million AUD | 0.0% |
| 2020 Q4 | -12.18 Million AUD | 0.0% |
| 2020 FY | -12.18 Million AUD | 52.09% |
| 2019 Q4 | -25.43 Million AUD | 0.0% |
| 2019 Q2 | -32 Million AUD | 0.0% |
| 2019 FY | -25.43 Million AUD | -400.76% |
| 2018 Q4 | 8.45 Million AUD | 0.0% |
| 2018 Q2 | 3 Million AUD | 0.0% |
| 2018 FY | 8.45 Million AUD | 770.21% |
| 2017 FY | -1.26 Million AUD | 75.44% |
| 2017 Q2 | -5.07 Million AUD | 0.0% |
| 2017 Q4 | -1.26 Million AUD | 0.0% |
| 2016 Q4 | -5.13 Million AUD | 0.0% |
| 2016 Q2 | -8.66 Million AUD | 0.0% |
| 2016 FY | -5.13 Million AUD | -3373.25% |
| 2015 Q4 | 157 Thousand AUD | 0.0% |
| 2015 FY | 157 Thousand AUD | -92.16% |
| 2015 Q2 | 984 Thousand AUD | 0.0% |
| 2014 Q2 | 2.27 Million AUD | 0.0% |
| 2014 FY | 2 Million AUD | 196.3% |
| 2014 Q4 | 2 Million AUD | 0.0% |
| 2013 Q4 | 676 Thousand AUD | 0.0% |
| 2013 Q2 | -2.12 Million AUD | 0.0% |
| 2013 FY | 676 Thousand AUD | 119.41% |
| 2012 Q4 | -3.48 Million AUD | 0.0% |
| 2012 FY | -3.48 Million AUD | 1.64% |
| 2011 FY | -3.54 Million AUD | -98.71% |
| 2011 Q4 | -3.54 Million AUD | 0.0% |
| 2010 Q4 | -1.78 Million AUD | 0.0% |
| 2010 FY | -1.78 Million AUD | -593.39% |
| 2009 Q4 | -257 Thousand AUD | 0.0% |
| 2009 FY | -257 Thousand AUD | 45.67% |
| 2008 FY | -473 Thousand AUD | -456.47% |
| 2008 Q4 | -473 Thousand AUD | 0.0% |
| 2007 Q4 | -85 Thousand AUD | 0.0% |
| 2007 FY | -85 Thousand AUD | -108.3% |
| 2006 FY | 1.02 Million AUD | -29.77% |
| 2006 Q4 | 1.02 Million AUD | 0.0% |
| 2005 Q4 | 1.95 Million AUD | 0.0% |
| 2005 FY | 1.45 Million AUD | 82.48% |
| 2004 FY | 799 Thousand AUD | -73.54% |
| 2004 Q4 | 1.29 Million AUD | 0.0% |
| 2003 FY | 3.02 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Althea Group Holdings Limited | 641 Thousand AUD | 1262.09% |
| Cann Group Limited | 70.82 Million AUD | 110.517% |
| ECS Botanics Holdings Ltd | -2.13 Million AUD | -249.124% |
| Ecofibre Limited | 18.75 Million AUD | 139.715% |
| Elixinol Wellness Limited | 554 Thousand AUD | 1444.585% |
| Hygrovest Limited | -189 Thousand AUD | -3841.27% |
| IDT Australia Limited | 3.96 Million AUD | 287.916% |
| Invion Limited | -783.52 Thousand AUD | -850.702% |
| Little Green Pharma Ltd | -532.33 Thousand AUD | -1299.307% |
| Live Verdure Ltd | -1.08 Million AUD | -589.25% |
| Vitura Health Limited | -6.02 Million AUD | -23.554% |
| Vita Life Sciences Limited | -24.24 Million AUD | 69.274% |